
Xiaohang Xu
Scientific
About Xiaohang Xu:
This is Xiaohang Xu from the School of Public Health, Zhejiang University. I am looking for a postdoctoral/research associate position. I recently completed my Ph.D. in Epidemiology and Health Statistics at Zhejiang University under Professor Xifeng Wu, defending my thesis "Study on Alternative Polyadenylation and Its Genetic Regulation in Non-Small Cell Lung Cancer" on May 27, 2025.
Experience
I have a strong background in multi-omics data analysis (WGS/RNA-seq), and my current work on the genetic regulation of APA has equipped me with expertise in APA/splicing quantification, GWAS, TWAS, QTL analysis, heritability estimation, and gene set enrichment analysis. In addition, I possess strong programming skills in R as well as excellent teamwork abilities.
Education
Sep. 2020 - Jun. 2025:
Zhejiang University, School of Public Health Hangzhou, China
Doctor of Medicine in Epidemiology and Health Statistics
Advisor: Prof. Xifeng Wu
Sep. 2015 – Jun. 2020:
China Medical University, School of Public Health Shenyang, China
Bachelor of Medicine in Preventive Medicine
Advisor: Prof. Yuanyuan Xu
Professionals in the same Scientific sector as Xiaohang Xu
Professionals from different sectors near Cambridge, Cambridge District, Cambridgeshire
Jobs near Cambridge, Cambridge District, Cambridgeshire
-
Principal/Sr Principal Scientist
4 days ago
GSK StevenageWe are seeking a talented and motivated individual to join our team as a Principal Scientist/Senior Principal Scientist in Applied Genetics within the R&D Translational Sciences team. · ...
-
Director, RWE Virology Safety Epidemiology
2 weeks ago
Gilead Sciences Cambridge, EnglandWe are looking for a Director to join our team at Gilead. As a people leader now or in the future, you will be key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfill their aspirations. · Responsible f ...
- GSK Stevenage
GSK seeks an Executive Medical Director for its Respiratory unit. The successful candidate will lead clinical development strategy from drug or program initiation through NDA/BLA submission. · ...